Quest Diagnostics launches genomic test service that aids in diagnosis for myeloid ne

[News]

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced LeukoVantage, an evidence-based genomic test service that aids in the diagnosis, prognosis, monitoring and selection of treatment for myeloid neoplasms, a group of hematologic malignancies that includes acute myeloid leukemia (AML), the most common form of adult acute leukemia, as well as myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPNs).

More... (http://www.news-medical.net/news/20150507/Quest-Diagnostics-launches-genomic-test-service-that-aids-in-diagnosis-for-myeloid-neoplasms.aspx)